PLGA-Biotin

Price range: $280.00 through $650.00

PLGA-Biotin is a biodegradable poly(lactide-co-glycolide) polymer functionalized with a terminal biotin group. The biotin moiety binds with exceptionally high affinity to streptavidin and avidin, enabling efficient bioconjugation, affinity purification, and targeted delivery while maintaining the excellent biodegradability and biocompatibility of PLGA. PLGA-Biotin is widely used in nanoparticle formulation, targeted drug delivery, diagnostics, and biomaterials research.

Product Name: PLGA-Biotin
Alternative Name: Biotin-PLGA
Polymer Type: Poly(D,L-lactide-co-glycolide)
Lactide Ratio: 50:50, 75:25, 85:15, Custom
Molecular Weight: 2k, 5k, 10k, 15k, 20k, 30k, 50k Da, Custom
Functional Group: Biotin
Appearance: White to off-white powder or solid
Solubility: Dichloromethane, Chloroform, THF, Acetone, DMF, DMSO
Storage: -20°C, dry and protected from moisture
Purity: Typically ≥95%

PLGA-Biotin biodegradable polymer structure

 

 

Description

General Description

PLGA-Biotin is a functional biodegradable polyester designed for affinity-based drug delivery and bioconjugation applications. The PLGA backbone provides controlled biodegradation and sustained drug release, while the terminal biotin group enables strong and specific interaction with streptavidin- and avidin-functionalized biomolecules.

PLGA-Biotin is commonly used to prepare targeted nanoparticles, microspheres, and biodegradable implants. The biotin functionality facilitates the immobilization or conjugation of antibodies, proteins, peptides, enzymes, nucleic acids, fluorophores, and other biomolecules through the streptavidin-biotin system, making it a versatile platform for targeted therapeutics, diagnostics, and molecular imaging.

The degradation rate of PLGA can be tailored by selecting different lactide ratios and molecular weights, allowing optimization of drug release profiles for a wide range of biomedical applications.

Applications

  • Targeted drug delivery
  • Nanoparticle formulation
  • Microsphere preparation
  • Streptavidin-based targeting
  • Protein immobilization
  • Antibody conjugation
  • Molecular imaging
  • Diagnostic assays
  • Tissue engineering
  • Biomaterials research

Features and Benefits

  • Terminal biotin functionality
  • High-affinity streptavidin/avidin binding
  • Biodegradable and biocompatible PLGA
  • Controlled degradation profile
  • Excellent drug encapsulation capability
  • Suitable for targeted delivery
  • Compatible with proteins and antibodies
  • Available in multiple molecular weights
  • Available with multiple PLGA compositions

Additional information

Molecular Weight

2000, 5000, 10K, 20K, 40K

Package Size

100mg, 1g